Editorial Board
Editors-in-Chief

  • Prof. Fanglin Guan view>>

    Bio-evidence Sciences Academy, Xi'an Jiaotong University , China

    Interests: Engaged in the integrated biological research of complex diseases, including tumor microenvironment and novel immunotherapeutic modalities, and research on the mechanisms and medical applications related to tumor cell vaccines, especially for the exploration of the mechanism of determining the biomarkers of complex diseases.

    Biography: Prof. Fanglin Guan is Dean at Xi'an Jiaotong University. He is engaged in the integrated biological research of complex diseases, including tumor microenvironment and novel immunotherapeutic modalities, and research on the mechanisms and medical applications related to tumor cell vaccines, especially for the exploration of the mechanism of determining the biomarkers of complex diseases.

Associate Editors

  • Prof. Xing Huang view>>

    Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, School of Medicine, Zhejiang University, China

    Interests: Investigation of the reciprocal control between cancer immunity and autophagy, cancer metabolism, as well as immunogenic cell death.

    Biography: Dr. Xing Huang is currently Professor/ Research Scientist at Zhejiang Provincial Key Laboratory of Pancreatic Disease in the First Affiliated Hospital of Zhejiang University School of Medicine. He was Assistant Professor in the MOE Key Laboratory of Developmental Genes and Human Disease in Southeast University. Dr. Xing Huang did his Postdoctoral training in the Metabolomics and Cell Biology platforms of Gustave Roussy Comprehensive Cancer Center, after receiving his Ph.D. degree in University of Science and Technology of China. Dr. Xing Huang, as corresponding author or/and first author, has recently published a number of research articles in high profile journals, including but not limited to Autophagy, EMBO Journal, Cancer Immunology Research, Oncogene, Molecular Cancer Therapeutics, Journal of Experimental & Clinical Cancer Research, and Journal of Biological Chemistry. Additionally, he has also collaborated with others and coauthored in a few papers, such as Gut, Seminars in Cancer Biology, Oncoimmunology, and BMC Genomics. Dr. Xing Huang serves as the editors of Frontiers in Oncology (2019 - present), Frontiers in Cell and Developmental Biology (2019 - present), and AME Publishing Company (2019 - present), as well as reviewers of Autophagy (2019 - present), Oncogenesis (2019 - present), Cancer Cell International (2019 - present), Cancer Translational Medicine (2019 - present), Journal of Experimental & Clinical Cancer Research (2018 - present), and World Journal of Surgical Oncology (2018 - present). He is also member of the Chinese Society of Biochemistry and Molecular Biology (CSBMB), Chinese Society for Immunology (CSI), and Chinese Society for Cell Biology (CSCB).

  • Prof. Min Wei

    Department of Breast Surgery, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University, China

    Interests: Estrogen receptor-negative breast cancer, Long non-coding RNA, Bioinformatics analysis, Prognostic markers.

Editorial Board Members

  • Prof. Jianfei Huang view>>

    Professor and Doctoral supervisor of oncology, Nantong University, China

    Interests: Screening, mechanism, and transformation of new targets for tumor diagnosis and treatment.

    Biography: Director of the Key Medical Discipline (Oncology) in Jiangsu Province, "333 Talent Project" in Jiangsu Province, and Key Medical Talents in Jiangsu Province, The first level of the "226 Talent Project" in Nantong, a Visiting scholar from the Pathology Department of MD Anderson Cancer Center in the United States, currently serves as the deputy director of the Clinical Epidemiology Branch of Jiangsu Medical Association, the member of the Precision Medical Branch of the Chinese Medical Biotechnology Association, the member of the Branch of the Organization Biological Sample Bank, the communication review expert of the National Natural Science Project, and the review expert of the doctoral/master's Thesis of the Degree Center of the Ministry of Education. Led multiple provincial and ministerial level scientific research projects, including 2 general projects funded by the National Natural Science Foundation of China and 1 key cutting-edge project funded by the Jiangsu Provincial Department of Science and Technology. He has published more than 30 papers included in SCI in international academic journals, participated in editing and publishing 3 monographs, and won 10 List of Chinese inventions patents. The research achievements have won the first prize for new technology introduction in Jiangsu Province multiple times and the third prize for medical progress in Jiangsu Province.

  • Prof. Guangsheng Pei view>>

    Research Assistant Professor UT MD anderson cancer cencer, USA

    Interests: Bioinformatics, Computational biology, Machine learning, Next generation sequencing data analysis.

    Biography: Dr. Guangsheng Pei became a faculty associate at UTHealth School of Biomedical Informatics (SBMI) on March 1, 2020. Prior to this position, Pei was a postdoctoral research fellow (11/2017-02/2020) at UTHealth SBMI. Pei interests span a broad range of research topics in systems biology and computational biology. During his doctoral program, he focused on integrating multi-omics data, investigating the regulatory mechanism of small RNA and metagenome-wide association study of gut microbiota in colorectal cancer. During his postdoc training, he focused on developing statistical methods to infer human complex diseases relevant tissue and cell type, developing deep learning model to prioritize causal variants from multiple complex diseases GWAS data. His researches also include analysis of single cell RNA sequencing data, in silico deconvolution analysis of single cell fingerprints in bulk RNA-seq profiles, and modeling their association with clinical outcomes. The Center for Precision Health has established the Cancer Genomics Core to drive medical innovation at the forefront of this promising technology. Dr. Pei will lead the next generation sequencing data analysis of this core. He will continue his research and collaborative with others to help better understanding the mechanism of multiple diseases.

  • Prof. Xuanye Cao view>>

    Scientist at Baylor College of Medicine, USA

    Interests: Human genetics and genomics, Single Cell RNA sequencing, Genome sequencing, molecular genetics, genetics and genomics, genetics of aging, Transcriptome, Transcription Factor AP-1Whole exome sequencing (WES), Whole genome sequencing (WGS), biochemical pathways, Metabolomics, Alternative Splicing, Alternative splicing (AS), Birth defects, Cancer, Rare diseases and disorders, cerebral folate deficiency, Autism Spectrum Disorders, congenital heart disease (CHD), ATAC-seq Data Analaysis, ChIP-Chromatin immunoprecipitation, CRISPR/Cas9, Epigenomics, Neural tube defect (NTD), Aging.

    Biography: Xuanye Cao got his PhD degree from Baylor College of Medicine. He is now an expert on human genetics, single cell genomics and NGS related research.

  • Dr. Ziheng Wang view>>

    Centre for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau SAR, China.

    Interests: My research mainly focuses on bioinformatics analysis and the use of machine learning methods to solve clinical problems. At the same time, I interested in developing more sophisticated protocols of single-cell multiple-omics, and studying major diseases, especially oncology using single-cell omics strategies. At the same time, I interested in basic and clinical research studies profiling the molecular pathology of diseases, investigating etiology and pathogenesis, and identifying humoral, genetic, and imaging biomarkers for clinical settings for diseases detection, diagnosis, prognosis, and prediction. I also used computational methods investigating diseases using high-throughput approaches, such as next-generation sequencing, single-cell omics, digital pathology, functional imaging, and others. Multiomics analysis includes multiple dimensions at the same time, such as genomics, epigenomics, transcriptome, proteomics and metabonomics. New biomarkers from multiple omics studies have been validated on more dimensions, with more precise mechanisms, diagnosis, and prognosis detection. Finally, I am very concerned about the high-quality care of patients and hope that various means can be used to improve their prognosis

  • Dr. Mingming Deng view>>

    Department of Respiratory Medicine, China-Japan Friendship Hospital, China

    Interests: Chronic obstructive pulmonary disease; Interventional Respiratory Disease

    Biography: Doctor of Medicine. Doctor graduated from Peking Union Medical College. Main research directions: clinical and basic research on chronic obstructive pulmonary disease, clinical and translational research in interventional respiratory disease. Published 23 SCI indexed articles as the first author/co first author, with a cumulative impact factor of 140 points, selected for the "2023-2025" Youth Talent Promotion Project of the Beijing Association for Science and Technology, and participated in multiple national and provincial level projects.

  • Dr. Yang Yang view>>

    Affiliated Hospital of Nantong University, China

    Interests: Oncology; Trauma; Spinal cord injury; Severe multiple injuries; Sepsis;

    Biography: Master Yang Yang is currently a lecturer in Nantong University. He received a master's degree in surgery from Nantong University in June 2011. His work experience includes lecturer/mentor of Nantong University, and he has worked in the Trauma Center of the Affiliated Hospital of Nantong University since August 2011. He has published 17 articles in SCI journals, presided over and participated in the National Natural Science Foundation of China, municipal science and technology projects, teaching and research projects of Nantong University and affiliated hospitals of Nantong University.